BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9727517)

  • 1. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
    Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
    Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated retinopathy vs recoverin-associated retinopathy.
    Keltner JL; Thirkill CE
    Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
    Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune retinopathy in the absence of cancer.
    Mizener JB; Kimura AE; Adamus G; Thirkill CE; Goeken JA; Kardon RH
    Am J Ophthalmol; 1997 May; 123(5):607-18. PubMed ID: 9152066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paraneoplastic retinopathy and anti-recoverin antibodies].
    Bataller L; Graus F; Dalmau J
    Neurologia; 2002 Mar; 17(3):156. PubMed ID: 11927105
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
    Adamus G
    Autoimmun Rev; 2003 Mar; 2(2):63-8. PubMed ID: 12848960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.
    Heckenlively JR; Fawzi AA; Oversier J; Jordan BL; Aptsiauri N
    Arch Ophthalmol; 2000 Nov; 118(11):1525-33. PubMed ID: 11074809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy.
    Thirkill CE; Keltner JL; Tyler NK; Roth AM
    Arch Ophthalmol; 1993 Jul; 111(7):931-7. PubMed ID: 8392327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
    Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
    Ohguro H; Ogawa K; Nakagawa T
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal degeneration under the effect of antibodies to recoverin.
    Bazhin AV; Slepova OS; Tikhomirova NK
    Bull Exp Biol Med; 2001 Apr; 131(4):350-2. PubMed ID: 11550024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy.
    Adamus G; Amundson D; MacKay C; Gouras P
    Arch Ophthalmol; 1998 Feb; 116(2):251-3. PubMed ID: 9488286
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer-associated retinopathy.
    Goldstein SM; Syed NA; Milam AH; Maguire AM; Lawton TJ; Nichols CW
    Arch Ophthalmol; 1999 Dec; 117(12):1641-5. PubMed ID: 10604671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
    Adamus G; Machnicki M; Elerding H; Sugden B; Blocker YS; Fox DA
    J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
    Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
    Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
    Adamus G; Ren G; Weleber RG
    BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental, cancer-induced retinopathy.
    Thirkill CE
    Ocul Immunol Inflamm; 1997 Mar; 5(1):55-65. PubMed ID: 9145694
    [No Abstract]   [Full Text] [Related]  

  • 20. The cancer-associated retinopathy antigen is a recoverin-like protein.
    Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
    Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.